Skip to main content

Onyx Scientific Aims for European Growth with New BD Hire

Written by: Editor
Published on: 14 Jun 2024

Onyx ScientificLeading small molecule CDMO Onyx Scientific has its sights set on European-wide commercial expansion with the new appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe. 

Europe is a key target market for Onyx Scientific, where it has established a successful reputation for its process chemistry, solid-state chemistry and API manufacturing capabilities over several years. International growth has been one of the driving factors behind the specialist CDMO increasing its non-GMP scale-up and GMP manufacturing capacity by 50%, and growing its staff headcount by 50% to 120 employees over the last 2-3 years.

With this new business development appointment, Onyx Scientific is looking to significantly increase its market share across the UK and Europe, strengthen its future growth prospects and maintain its commitment to providing exceptional customer service to its international clients.


Courtnie is a highly experienced business development manager, having previously worked for pharmaceutical market intelligence service Citeline, hygiene healthcare and nutrition brand specialist Reckitt, and consumer self-care company Perrigo in a range of commercially focused roles. 

She has experience in spearheading strategic initiatives to drive substantial growth in market share, leveraging her pharmaceutical science background to enhance product development and market positioning.

Commenting on the new appointment, Courtnie said, ”The team at Onyx are enthusiastic, talented and committed to achieving high quality science and customer experience and I am excited to be part of the team. I look forward to leveraging my experience to build solid relationships with existing and new customers, fostering growth and expanding our presence across the UK and Europe. My skills and dedication will help drive Onyx Scientific’s strategic objectives and deliver outstanding business results.”

Onyx Scientific’s Commercial Manager, Dr Chris Atherton, added, “Our appointment of Courtnie as Business Development Manager bolsters our plans for commercial expansion across the UK and Europe. She has a strong track record of negotiating high-stakes deals, fostering strong partnerships and significantly expanding the market footprint of the organisations she has worked for, capitalising on new business opportunities and contributing significantly to revenue growth. I am confident that Courtnie will make a strong addition to our commercial team.”